CMI/Compas Guidance to Pharma Marketers During COVID-19 Recovery
Nearly four months after the outbreak, as new COVID-19 cases appear to stabilize, all 50 U.S. states have taken steps towards reopening. “Back to normal” as we once knew it may never be achieved, but instead a reimagined new normal will help move us forward.
Reprints Still Valued by HCPs
To support busy HCPs, brand marketers must deliver more than just compelling content. Their brands must also create a customer experience that understands their needs and preferences.
The Importance of Print Media in Today’s NPP Channel Mix
In an industry surrounded by digital marketing, it’s easy to forget the importance of print media in the overall non-personal promotional (NPP) channel mix. What we as marketers often overlook is that print media can be a strategic complement to digital, and not an alternative to it. Print media has often been viewed as a foundation to most marketing plans, playing an integral part of reaching key customers.
Strategic Media Planning: Addressing Misconceptions and Highlighting Best Practices for Successful Engagement in Pharma Marketing
This POV will address common misconceptions in media planning and show how a strategic approach can make media planning one of the most important tools in marketing.
Reprint Purchasing – New Era, New Strategies – Best Practices
The pharma content landscape is undergoing a sea change and we as an industry are tasked with finding more strategic…
How to Maximize Medical Reprint Investment in Wake of the Sunshine Act and Other Industry Challenges
Over the last few years the commercial landscape in our industry has changed significantly. We have to work harder and…
Impact of iPad on Medical Reprints Market
Background: More pharmaceutical companies are moving away from traditional paper reprints and are arming their sales force with digital ePrints…